Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Unspecified Adult Solid Tumor, Protocol Specific × Immunization, Passive × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Topotecan 2 timcodar 1 sargramostim 1 Tissue Plasminogen Activator 1 Radiosurgery 1 Paclitaxel 1 Muromonab-CD3 1 Irinotecan 1 Interferon-alpha 1 Immunization, Passive 1 Gemcitabine 1 Docetaxel 1 Diathermy 1 Cyclophosphamide 1 Cisplatin 1 Captopril 1 Biological Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002482 2013-11-06

Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon ⚡